Home › Compare › CORBF vs SBUX

CORBF vs SBUX: Dividend Comparison 2026

CORBF yields 190.48% · SBUX yields 2.84%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CORBF wins by $90.09M in total portfolio value
10 years
CORBF
CORBF
● Live price
190.48%
Share price
$1.05
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$90.25M
Annual income
$44,400,251.00
Full CORBF calculator →
SBUX
SBUX
● Live price
2.84%
Share price
$86.72
Annual div
$2.46
5Y div CAGR
48.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$167.0K
Annual income
$71,136.45
Full SBUX calculator →

Portfolio growth — CORBF vs SBUX

📍 CORBF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCORBFSBUX
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CORBF + SBUX cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
CORBF pays
SBUX pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CORBF
Annual income on $10K today (after 15% tax)
$16,190.48/yr
After 10yr DRIP, annual income (after tax)
$37,740,213.35/yr
SBUX
Annual income on $10K today (after 15% tax)
$241.12/yr
After 10yr DRIP, annual income (after tax)
$60,465.98/yr
At 15% tax rate, CORBF beats the other by $37,679,747.37/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CORBF + SBUX for your $10,000?

CORBF: 50%SBUX: 50%
100% SBUX50/50100% CORBF
Portfolio after 10yr
$45.21M
Annual income
$22,235,693.73/yr
Blended yield
49.18%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SBUX right now

CORBF
Analyst Ratings
1
Buy
2
Hold
Consensus: Hold
Altman Z
4.7
Piotroski
8/9
SBUX
Analyst Ratings
28
Buy
27
Hold
3
Sell
Consensus: Buy
Price Target
$104.00
+19.9% upside vs current
Range: $90.00 — $120.00
Altman Z
2.6
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CORBF buys
0
SBUX buys
0
No recent congressional trades found for CORBF or SBUX in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCORBFSBUX
Forward yield190.48% ✓2.84%
Annual dividend / share$2.00$2.46 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%48.3% ✓
Portfolio after 10y$90.25M$167.0K ✓
Annual income after 10y$44,400,251.00 ✓$71,136.45
Total dividends collected$84.82M$136.4K ✓
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary
Analyst consensusHoldBuy

Year-by-year: CORBF vs SBUX ($10,000, DRIP)

YearCORBF PortfolioCORBF Income/yrSBUX PortfolioSBUX Income/yrGap
1← crossover$29,748$19,047.62$11,121$420.68+$18.6K → CORBF
2$84,785$52,955.26$12,548$648.40+$72.2K → CORBF
3$231,777$141,056.55$14,440$1,013.98+$217.3K → CORBF
4$608,380$360,378.77$17,068$1,617.30+$591.3K → CORBF
5$1,535,024$884,057.33$20,912$2,649.52+$1.51M → CORBF
6$3,727,144$2,084,668.10$26,875$4,499.29+$3.70M → CORBF
7$8,718,621$4,730,577.40$36,771$8,014.12+$8.68M → CORBF
8$19,670,865$10,341,940.93$54,542$15,197.11+$19.62M → CORBF
9$42,854,727$21,806,900.51$89,602$31,242.49+$42.77M → CORBF
10$90,254,808$44,400,251.00$167,011$71,136.45+$90.09M → CORBF

CORBF vs SBUX: Complete Analysis 2026

CORBF — Stock

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.

Full CORBF Calculator →

SBUX — Consumer Discretionary

Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of specialty coffee worldwide. The company operates through three segments: North America, International, and Channel Development. Its stores offer coffee and tea beverages, roasted whole beans and ground coffees, single serve products, and ready-to-drink beverages; and various food products, such as pastries, breakfast sandwiches, and lunch items. The company also licenses its trademarks through licensed stores, and grocery and foodservice accounts. The company offers its products under the Starbucks, Teavana, Seattle's Best Coffee, Evolution Fresh, Ethos, Starbucks Reserve, and Princi brands. As of October 3, 2021, it operated 16,826 company-operated and licensed stores in North America; and 17,007 company-operated and licensed stores internationally. The company was founded in 1971 and is based in Seattle, Washington.

Full SBUX Calculator →
📬

Get this CORBF vs SBUX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CORBF vs SCHDCORBF vs JEPICORBF vs OCORBF vs KOCORBF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.